Provided by Tiger Trade Technology Pte. Ltd.

Absci Corporation.

10.75
-0.0200-0.19%
Pre-market: 10.890.1400+1.30%05:34 EDT
Volume:4.61M
Turnover:50.30M
Market Cap:1.84B
PE:-13.44
High:11.27
Open:10.80
Low:10.55
Close:10.77
52wk High:12.06
52wk Low:2.24
Shares:171.61M
Float Shares:156.49M
Volume Ratio:1.23
T/O Rate:2.94%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7999
EPS(LYR):-0.8421
ROE:-57.72%
ROA:-34.10%
PB:7.50
PE(LYR):-12.77

Loading ...

Absci is Maintained at Buy by Truist Securities

Dow Jones
·
Jul 02

BTIG Remains a Buy on AbSci (ABSI)

TIPRANKS
·
Jul 01

Healthcare Stocks Have Become a Haven for Investors Ditching Tech

Dow Jones
·
Jun 27

Absci price target raised to $10 from $4.10 at Morgan Stanley

TIPRANKS
·
Jun 25

Absci (ABSI) Is Up 40.3% After Positive ABS-201 Data And Equity Raise Has The Bull Case Changed?

Simply Wall St.
·
Jun 25

Absci's ABS-201 Phase 1 Data De-Risks Hair Loss Program Ahead of Efficacy Readout, Truist Says

MT Newswires Live
·
Jun 25

Analysts Have Conflicting Sentiments on These Healthcare Companies: InMode (INMD) and AbSci (ABSI)

TIPRANKS
·
Jun 25

Analysts Are Bullish on These Healthcare Stocks: Inmune Bio (INMB), AbSci (ABSI)

TIPRANKS
·
Jun 25

Absci is Maintained at Buy by BTIG

Dow Jones
·
Jun 25

Top Midday Gainers

MT Newswires Live
·
Jun 25

Sector Update: Healthcare Stocks Rise Pre-Bell Wednesday

MT Newswires Live
·
Jun 24

U.S. Stocks on the Move-take-two, Wendy's, Absci

Reuters
·
Jun 24

Absci Rises on Positive Hair-loss Drug Data

Reuters
·
Jun 24

Absci Corp Shares up 14% Premarket After Co Reports Early-stage Trial Data from Its Ai-designed Hair Loss Drug

THOMSON REUTERS
·
Jun 24

Absci prices 13.5M shares at $7.41 in public offering

TIPRANKS
·
Jun 24

Absci reports Phase 1 data from human trial of ABS-201

TIPRANKS
·
Jun 24

Absci Prices 13,495,277-share Follow-on Offering at $7.41 Per Share to Raise $100 Million

Reuters
·
Jun 24

Absci Corp - Prices Underwritten Offering of 13.5 Mln Shares at $7.41 Per Share

THOMSON REUTERS
·
Jun 24

Absci Corp - Eli Lilly & Company and Others Participate in $100 Mln Absci Offering

THOMSON REUTERS
·
Jun 24

Absci Announces Pricing of $100 Million Underwritten Offering with Leading Strategic and Financial Investors

THOMSON REUTERS
·
Jun 24